These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28468916)

  • 21. RNA interfering targeting human leukocyte antigen-G enhanced immune surveillance mediated by the natural killer cells on hepatocellular carcinoma.
    Zeng XC; Zhang T; Huang DH; Wang GY; Chen W; Li H; Zhang J; Fang TL; Zhang Q; Chen GH
    Ann Clin Lab Sci; 2013; 43(2):135-44. PubMed ID: 23694787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibroblast growth factor-2 enhances NK sensitivity of hepatocellular carcinoma cells.
    Tsunematsu H; Tatsumi T; Kohga K; Yamamoto M; Aketa H; Miyagi T; Hosui A; Hiramatsu N; Kanto T; Hayashi N; Takehara T
    Int J Cancer; 2012 Jan; 130(2):356-64. PubMed ID: 21351090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans.
    Ishiyama K; Ohdan H; Ohira M; Mitsuta H; Arihiro K; Asahara T
    Hepatology; 2006 Feb; 43(2):362-72. PubMed ID: 16440347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells.
    Sprinzl MF; Reisinger F; Puschnik A; Ringelhan M; Ackermann K; Hartmann D; Schiemann M; Weinmann A; Galle PR; Schuchmann M; Friess H; Otto G; Heikenwalder M; Protzer U
    Hepatology; 2013 Jun; 57(6):2358-68. PubMed ID: 23424039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoregulation of dendritic and T cells by alpha-fetoprotein in patients with hepatocellular carcinoma.
    Ritter M; Ali MY; Grimm CF; Weth R; Mohr L; Bocher WO; Endrulat K; Wedemeyer H; Blum HE; Geissler M
    J Hepatol; 2004 Dec; 41(6):999-1007. PubMed ID: 15582134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency and Implications of Natural Killer and Natural Killer T Cells in Hepatocellular Carcinoma.
    Zahran AM; Abdel-Meguid MM; Ashmawy AM; Rayan A; Elkady A; Elsherbiny NM; Hetta HF
    Egypt J Immunol; 2018 Jun; 25(2):45-52. PubMed ID: 30600947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy.
    Sun C; Sun HY; Xiao WH; Zhang C; Tian ZG
    Acta Pharmacol Sin; 2015 Oct; 36(10):1191-9. PubMed ID: 26073325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of alpha-fetoprotein-specific CD4- and CD8-mediated T-cell response using RNA-transfected dendritic cells.
    Zhang HM; Zhang LW; Ren J; Fan L; Si XM; Liu WC
    Cell Immunol; 2006 Feb; 239(2):144-50. PubMed ID: 16814271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A bispecific protein rG7S-MICA recruits natural killer cells and enhances NKG2D-mediated immunosurveillance against hepatocellular carcinoma.
    Wang T; Sun F; Xie W; Tang M; He H; Jia X; Tian X; Wang M; Zhang J
    Cancer Lett; 2016 Mar; 372(2):166-78. PubMed ID: 26791237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural killer cell activity in hepatocellular carcinoma. In vitro and in vivo responses to interferon.
    Dunk AA; Novick D; Thomas HC
    Scand J Gastroenterol; 1987 Dec; 22(10):1245-50. PubMed ID: 2448865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of ex vivo peripheral and intrahepatic α-fetoprotein-specific CD4+ responses in hepatocellular carcinoma.
    Witkowski M; Spangenberg HC; Neumann-Haefelin C; Büttner N; Breous E; Kersting N; Drognitz O; Hopt UT; Blum HE; Semmo N; Thimme R
    Int J Cancer; 2011 Nov; 129(9):2171-82. PubMed ID: 21170957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of hepatocellular carcinoma growth in mice via leptin, is associated with inhibition of tumor cell growth and natural killer cell activation.
    Elinav E; Abd-Elnabi A; Pappo O; Bernstein I; Klein A; Engelhardt D; Rabbani E; Ilan Y
    J Hepatol; 2006 Mar; 44(3):529-36. PubMed ID: 16310278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy.
    Ohira M; Ohdan H; Mitsuta H; Ishiyama K; Tanaka Y; Igarashi Y; Asahara T
    Transplantation; 2006 Dec; 82(12):1712-9. PubMed ID: 17198265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in immunological function after treatment with transarterial chemoembolization plus radiofrequency ablation in hepatocellular carcinoma patients.
    Guan HT; Wang J; Yang M; Song L; Tong XQ; Zou YH
    Chin Med J (Engl); 2013; 126(19):3651-5. PubMed ID: 24112158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO.
    Li T; Yang Y; Hua X; Wang G; Liu W; Jia C; Tai Y; Zhang Q; Chen G
    Cancer Lett; 2012 May; 318(2):154-61. PubMed ID: 22182446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immunosuppression role of alpha-fetoprotein in human hepatocellular carcinoma.
    Meng W; Bai B; Bai Z; Li Y; Yue P; Li X; Qiao L
    Discov Med; 2016 Jun; 21(118):489-94. PubMed ID: 27448785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells.
    Hirofuji H; Kakumu S; Fuji A; Ohtani Y; Murase K; Tahara H
    Clin Exp Immunol; 1987 May; 68(2):348-56. PubMed ID: 2820634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of CD4+ T-Cell responses to a novel alpha-fetoprotein-derived epitope in hepatocellular carcinoma patients.
    Alisa A; Ives A; Pathan AA; Navarrete CV; Williams R; Bertoletti A; Behboudi S
    Clin Cancer Res; 2005 Sep; 11(18):6686-94. PubMed ID: 16166448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [NK activity in various liver diseases--especially the relation between NK activity and reserve function of the liver in liver cirrhosis and hepatocellular carcinoma].
    Takagi H; Sakurai S; Uehara M; Yamada S; Kobayashi S
    Nihon Gan Chiryo Gakkai Shi; 1989 Oct; 24(10):2369-74. PubMed ID: 2559127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural killer cells involved in tumour immune escape of hepatocellular carcinomar.
    Han C; Jiang Y; Wang Z; Wang H
    Int Immunopharmacol; 2019 Aug; 73():10-16. PubMed ID: 31078921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.